Reliance Group Makes Foray Into Biotech Sector

Reliance group is making a major foray in biotechnology sector with research and development initiated on a bevy of new products.

Reliance Life Sciences, the company which has been set up by the group to foray in this area, has already started work on ReliCordan enriched blood that is used for treating patients with thalassemia, a serious blood disorder. Details of the project, the first of its kind in the private sector, is still under wraps.

The group is also working on producing artificial skin products which will have a variety of uses. These products could be used for patients with burns, for testing of drugs and cosmetics on artificial skins, anti-cancer drug testing and as a sterile medium for stem cell preservation at low temperature.

The first batch of artificial skin products are expected to be tested abroad. The product could have large commercial usages and could become a large revenue earner for the group later on.

The group is also working on products in the area of assisted reproduction. A Reliance spokes- person, when contacted on the details of the group